160 related articles for article (PubMed ID: 7685092)
1. Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1993 Apr; 13(4):271-80. PubMed ID: 7685092
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald N; Cuckle H; Wu TS; George L
Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome.
Crandall BF; Golbus MS; Goldberg JD; Matsumoto M
Prenat Diagn; 1991 Jun; 11(6):377-80. PubMed ID: 1717969
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA
Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
8. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
Canick JA; Knight GJ; Palomaki GE; Haddow JE; Cuckle HS; Wald NJ
Br J Obstet Gynaecol; 1988 Apr; 95(4):330-3. PubMed ID: 2968116
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Leporrier N; Herrou M; Herlicoviez M; Leymarie P
Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
[TBL] [Abstract][Full Text] [Related]
10. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
11. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
Kim SY; Kim SK; Lee JS; Kim IK; Lee K
Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
[TBL] [Abstract][Full Text] [Related]
12. Placental synthesis of oestriol in Down's syndrome pregnancies.
Newby D; Aitken DA; Howatson AG; Connor JM
Placenta; 2000; 21(2-3):263-7. PubMed ID: 10736251
[TBL] [Abstract][Full Text] [Related]
13. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
15. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
16. First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects.
Aitken DA; McCaw G; Crossley JA; Berry E; Connor JM; Spencer K; Macri JN
Prenat Diagn; 1993 Aug; 13(8):681-9. PubMed ID: 8284287
[TBL] [Abstract][Full Text] [Related]
17. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE
Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652
[TBL] [Abstract][Full Text] [Related]
20. [Significance of the maternal levels of serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol in various congenital developmental defects in pregnancy trimester II].
Kostiuk EV; Zolotukhina TV; Kuznetsov MI
Genetika; 1992 Sep; 28(9):158-62. PubMed ID: 1282117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
